NDA Group, PharmApprove Announce Strategic Alliance

June 9, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

Two leading drug development and regulatory consultancies announced they have formed a new strategic alliance to help life science companies navigate an increasingly complex global environment.

Two leading drug development and regulatory consultancies announced they have formed a new strategic alliance to help life science companies navigate an increasingly complex global environment. PharmApprove – a strategic regulatory, and scientific communications consultancy based in the US – and NDA Group – a European-based regulatory, pharmacovigilance and Health Technology Assessment (HTA) consultancy – are collaborating to provide the life science industry with integrated global regulatory, scientific and market access communications solutions.

 

Read the full release here.